CARE Canadian ALS Riluzole Evaluation

Autores
Categoría Estudio primario
Registro de estudiosclinicaltrials.gov
Año 2001
Cargando información sobre las referencias
Evaluate the efficacy of riluzole 50-mg bid defined by comparing the percentage of riluzole-treated subjects who experienced death, permanently assisted ventilation (PAV) or tracheostomy, to a group of recent historical controls for the treatment of amyotrophic lateral sclerosis (ALS).
Epistemonikos ID: fef3f3c483d818179fb012f793c10edd749b8ed0
First added on: May 04, 2024